- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07669987
The Impact of Preoperative Quantitative Flow Reserve (QFR) on Early Postoperative Radial Artery Graft Outcomes in Coronary Artery Bypass Grafting (QFR-RADIAL)
The goal of this observational study is to learn about the long-term effects of Quantitative Flow Reserve (QFR) assessment in patients undergoing Coronary Artery Bypass Grafting (CABG). The main question it aims to answer is:
Does preoperative QFR measurement improve graft outcomes and reduce major adverse cardiac and cerebrovascular events (MACE) in patients undergoing CABG?
Participants who are scheduled for CABG and have undergone preoperative QFR assessment will be followed for one year post-surgery. They will provide data on graft patency and report any occurrences of MACE through regular follow-up visits and questionnaires about their health status.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Tong Ding, MD
- Phone Number: +8613132150173
- Email: dt1067723747@gmail.com
Study Locations
-
-
Beijing Municipality
-
Beijing, Beijing Municipality, China, 100191
- Recruiting
- Peking University Third Hospital
-
Contact:
- Tong Ding
- Phone Number: 13132150173
- Email: dt1067723747@gmail.com
-
Principal Investigator:
- Yunpeng Ling, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients aged 18 to 80 years.
- Patients whose angina pectoris significantly affects daily life and work, and for whom conservative medical treatment is ineffective, requiring coronary artery bypass grafting (CABG).
- Preoperative coronary angiography data are available for quantitative flow ratio (QFR) analysis.
- Patients with severe stenosis, defined as greater than 70% stenosis, in the three main coronary artery branches, including the left anterior descending artery, circumflex artery, and right coronary artery, with or without left main coronary artery stenosis greater than 50%.
Exclusion Criteria:
- Patients who cannot tolerate CABG due to comorbidities or complications.
- Patients requiring urgent CABG or percutaneous coronary intervention (PCI).
- Patients with significant congestive heart failure or hemodynamic instability.
- Patients with a history of previous CABG or PCI within the past 6 months.
- Patients who have experienced a stroke within the past 6 months.
- Patients requiring concurrent cardiac procedures, such as valve surgery, maze surgery, radiofrequency ablation, or pacemaker implantation.
- Patients with allergies to contrast agents or antiplatelet medications, or with contraindications to antiplatelet medications due to bleeding risks.
- Patients with a significant history of bleeding, marked leukopenia, neutropenia, thrombocytopenia, anemia, or bleeding diathesis.
- Patients currently participating in other prospective clinical studies.
- Patients who are unwilling to participate in this study.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The patency of the graft vessels one year postoperatively.
Time Frame: 12 months
|
The patency of the radial artery graft in subjects who underwent coronary artery bypass grafting (CABG) one year postoperatively was assessed using coronary computed tomography angiography (CCTA) or conventional angiography (CAG), and its functional status was evaluated.
Patency was classified according to the FitzGibbon classification system: Grade A indicates widely patent grafts, Grade B indicates grafts with limited flow (stenosis < 50%), Grade S denotes the presence of string sign (stenosis > 50% at any location of the graft), and Grade O signifies graft occlusion.
Grades S and O were considered indicative of graft failure.
The angiographic/CTA evaluations were conducted by two clinical physicians who were blinded to the preoperative quantitative flow ratio (QFR) values.
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The incidence of major adverse cardiovascular and cerebrovascular events (MACCE) at one year post-surgery, including all-cause mortality, non-fatal myocardial infarction, non-fatal stroke, and repeat revascularization.
Time Frame: 12 months
|
12 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- QFR-RADIAL
- BYSYZD2023015 (Other Grant/Funding Number: Peking university third hospital)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Radial Artery
-
University Hospital of PatrasRecruitingDistal Radial Artery Access (dTRA) | Radial Artery AccessGreece
-
Oregon Health and Science UniversityCompleted
-
Aarhus University Hospital SkejbyTerumo CorporationCompleted
-
Wonju Severance Christian HospitalCompletedRadial ArteryKorea, Republic of
-
Diskapi Teaching and Research HospitalNot yet recruitingCardiac Surgery | Radial Artery Cannulation | Cardiac Surgery in Adult Patient | Arterial Cannulation | Radial Artery CatheterizationTurkey (Türkiye)
-
Centre Hospitalier Universitaire de NīmesCompleted
-
Ting XuEnrolling by invitation
-
Cairo UniversityCompletedRadial Artery CanulationEgypt
-
Kasr El Aini HospitalRecruiting
-
Qianfoshan HospitalRecruitingPregnancy | Radial ArteryChina
Clinical Trials on Observational
-
Massachusetts General HospitalRecruiting
-
Taysha Gene Therapies, Inc.Withdrawn
-
University Hospital, AntwerpUniversiteit AntwerpenUnknownType 1 Diabetes | Diastolic Dysfunction | Coronary Artery CalcificationsBelgium
-
University of Castilla-La ManchaRecruitingKnee OsteoarthritisSpain
-
University Hospital, Basel, SwitzerlandCompletedPostoperative Complications | Intraoperative Complications | Patient Safety | Risk ManagementNew Zealand, Switzerland, United States, Netherlands, Spain, Austria, Turkey, United Kingdom, Australia, Greece, Ireland, Italy
-
St. Louis UniversityRecruitingVertebral Artery StenosisUnited States
-
Drexel UniversityCompletedOsteoporosisUnited States
-
University of ManitobaCompletedObesity | Pregnancy | Cesarean SectionCanada
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); National Center for Advancing Translational...CompletedHead and Neck Cancer | Chronic Obstructive Pulmonary Disease | Lung CancerUnited States
-
Oslo University HospitalThe Research Council of NorwayRecruitingMesothelioma | Pseudomyxoma Peritonei | Colorectal Carcinoma | Ovarian CarcinomaNorway